Difference between revisions of "Intracystic papillary carcinoma of the breast"

Jump to navigation Jump to search
m
(tweak formating)
m (→‎Microscopic: wikify)
Line 66: Line 66:
***ER staining will be heterologous in a benign lesion.
***ER staining will be heterologous in a benign lesion.
***Myoepithelial markers (calponin/p63/SMA +ve)s hould be positive in a benign lesion.   
***Myoepithelial markers (calponin/p63/SMA +ve)s hould be positive in a benign lesion.   
*[[Papillary ductal carcinoma in situ]]
*[[Papillary ductal carcinoma in situ]].
**Papillary DCIS shows myoepithelial cells (calponin/p63/SMA +ve) at the periphery of the involved spaces
**Papillary DCIS shows myoepithelial cells (calponin/p63/SMA +ve) at the periphery of the involved spaces
**But papillary DCIS should be negative for myoepithelial cells within the focus of DCIS
**But papillary DCIS should be negative for myoepithelial cells within the focus of DCIS
**Papillary intracystic carcinoma does not show myoepithelial cells at the periphery of the involved spaces
**Papillary intracystic carcinoma does not show myoepithelial cells at the periphery of the involved spaces
*Invasive papillary carcinoma of the breast
*[[Invasive papillary carcinoma of the breast]].
**Similar architecture but no cystic space, frankly invasive.
**Similar architecture but no cystic space, frankly invasive.
**Very rare.
**Very rare.
48,833

edits

Navigation menu